Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Treasury Shares (2019 - 2025)

Historic Treasury Shares for aTYR PHARMA (ATYR) over the last 7 years, with Q3 2025 value amounting to $20108.0.

  • aTYR PHARMA's Treasury Shares fell 5121.31% to $20108.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $20108.0, marking a year-over-year decrease of 5121.31%. This contributed to the annual value of $41216.0 for FY2024, which is 3491.56% down from last year.
  • As of Q3 2025, aTYR PHARMA's Treasury Shares stood at $20108.0, which was down 5121.31% from $20108.0 recorded in Q2 2025.
  • In the past 5 years, aTYR PHARMA's Treasury Shares registered a high of $121438.0 during Q2 2022, and its lowest value of $7500.0 during Q1 2021.
  • Its 5-year average for Treasury Shares is $52328.8, with a median of $41216.0 in 2024.
  • As far as peak fluctuations go, aTYR PHARMA's Treasury Shares soared by 151917.33% in 2022, and later crashed by 5850.47% in 2024.
  • Over the past 5 years, aTYR PHARMA's Treasury Shares (Quarter) stood at $7500.0 in 2021, then surged by 1519.17% to $121438.0 in 2022, then crashed by 47.85% to $63327.0 in 2023, then tumbled by 34.92% to $41216.0 in 2024, then tumbled by 51.21% to $20108.0 in 2025.
  • Its last three reported values are $20108.0 in Q3 2025, $20108.0 for Q2 2025, and $20108.0 during Q1 2025.